We are live on ! Find out more
KERX

Keryx Biopharmaceuticals Inc
KERX

Delisted

KERX was delisted on the 12th of December, 2018.

Back to rankings

119 hedge funds and large institutions have $424M invested in Keryx Biopharmaceuticals Inc in 2017 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 29 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more call options, than puts

Call options by funds: $6.38M | Put options by funds: $3.8M

24% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 29

11% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 18

6% more capital invested

Capital invested by funds: $399M → $424M (+$25.1M)

3% less funds holding

Funds holding: 123 → 119 (-4)

Holders
119
Holders Change
-4
Holders Change %
-3.25%
% of All Funds
2.96%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
36
Reduced
29
Closed
18
Calls
$6.38M
Puts
$3.8M
Net Calls
+$2.59M
Net Calls Change
+$3.89M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$29.6M
2
CLM
ClearBridge LLC (Maryland)
Maryland
+$7.14M
3
OWIM
Old West Investment Management
California
+$3.39M
4
State Street
State Street
Massachusetts
+$3.19M
5
Millennium Management
Millennium Management
New York
+$2.29M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$7.57M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.57M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$2.49M
4
QIM
Quantitative Investment Management
Virginia
-$1.17M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
Janney Montgomery Scott
51
Janney Montgomery Scott
Pennsylvania
$410K +$82.2K +15,000 +29%
AIM
52
Advantage Investment Management
Iowa
$405K +$59.9K +10,934 +20%
WMSA
53
Weiss Multi-Strategy Advisers
New York
$400K +$5.48K +1,000 +2%
State Board of Administration of Florida Retirement System
54
State Board of Administration of Florida Retirement System
Florida
$399K – – –
Manulife (Manufacturers Life Insurance)
55
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$392K +$41.8K +7,638 +14%
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
$338K -$6.62K -1,209 -2%
OC
57
Oppenheimer & Co
New York
$335K -$82.8K -15,111 -22%
MLICM
58
Metropolitan Life Insurance Company (MetLife)
New York
$306K -$79.1K -14,444 -23%
AIG
59
American International Group
New York
$300K +$17.6K +3,220 +7%
AG
60
Advisor Group
Arizona
$295K -$24.7K -4,505 -9%
NFA
61
Nationwide Fund Advisors
Ohio
$283K -$19.8K -3,622 -7%
NFC
62
Northeast Financial Consultants
Connecticut
$283K – – –
LPL Financial
63
LPL Financial
California
$282K +$208K +38,028 +352%
MIM
64
Marco Investment Management
Georgia
$279K – – –
T. Rowe Price Associates
65
T. Rowe Price Associates
Maryland
$273K – – –
BWP
66
Baldwin Wealth Partners
Massachusetts
$267K – – –
UBS AM
67
UBS AM
Illinois
$235K – – –
VWM
68
Venturi Wealth Management
Texas
$232K +$219K +40,000 New
Squarepoint
69
Squarepoint
New York
$230K -$84.7K -15,463 -29%
Creative Planning
70
Creative Planning
Kansas
$226K – – –
Stifel Financial
71
Stifel Financial
Missouri
$207K +$19.1K +3,478 +11%
Public Employees Retirement Association of Colorado
72
Public Employees Retirement Association of Colorado
Colorado
$199K – – –
VOYA Investment Management
73
VOYA Investment Management
Georgia
$187K – – –
LCC
74
Lincoln Capital Corp
Rhode Island
$187K +$19.2K +3,500 +13%
PHS
75
Pekin Hardy Strauss
Illinois
$185K – – –
1 2
3
4 5

KERX Hedge Fund Activity: Q1 2017 in Review

119 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q1 2017, worth a combined $424M — up 6.3% from $399M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new KERX positions and 18 closed out — a net gain of 2 holders — while 36 added to existing stakes and 29 trimmed.

The largest buyer was BlackRock, adding an estimated $29.6M. The largest seller was Deerfield Management, exiting entirely with an estimated $7.57M sold.

  • 119 institutional investors held Keryx Biopharmaceuticals Inc (KERX) as of Q1 2017, down from 123 in Q4 2016.
  • Funds reported $424M of Keryx Biopharmaceuticals Inc stock for Q1 2017, up 6.3% quarter-over-quarter.
  • 20 funds opened new Keryx Biopharmaceuticals Inc positions in Q1 2017 and 18 closed out, a net change of +2 holders.
  • The largest Keryx Biopharmaceuticals Inc buyer in Q1 2017 was BlackRock, an estimated $29.6M added.
  • The largest Keryx Biopharmaceuticals Inc seller in Q1 2017 was Deerfield Management, an estimated $7.57M sold.

Based on aggregated 13F filings for Q1 2017.